Strategic autonomy and the competitiveness of Europe's innovative pharmaceutical sector : a wake-up call

It is high time for Europe to break its relative decline in the pharmaceutical sector. Europe used to be the preeminent region in the world for Research and Development and innovation in the sector - being the location for a majority of R&D and the development of new medicines. However, its competitiveness has been going down for several decades - and, in more recent time, the pace of the decline is now accelerating. Europe is not just outpaced by the United States. Unless there is a new direction, China will soon be ahead of Europe too.